The Shape Effect of Mesoporous Silica Nanoparticles on Biodistribution, Clearance, and Biocompatibility in Vivo

被引:715
|
作者
Huang, Xinglu [1 ]
Li, Linlin [1 ]
Liu, Tianlong [1 ]
Hao, Nanjing [1 ,2 ]
Liu, Huiyu [1 ]
Chen, Dong [1 ]
Tang, Fangqiong [1 ]
机构
[1] Chinese Acad Sci, Lab Controllable Preparat & Applicat Nanomat, Tech Inst Phys & Chem, Beijing 100190, Peoples R China
[2] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China
关键词
mesoporous silica nanoparticles (MSNs); shape; in vivo; biodistribution; clearance; biocompatibility; MESENCHYMAL STEM-CELLS; DRUG-DELIVERY; PARTICLE-SIZE; GOLD NANOPARTICLES; HEMOLYTIC-ACTIVITY; URINARY-EXCRETION; SURFACE-CHARGE; CANCER-THERAPY; QUANTUM DOTS; DESIGN;
D O I
10.1021/nn200365a
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In our previous study we reported that the interaction of nanoparticles with cells can be influenced by particle shape, but until now the effect of particle shape on In vivo behavior remained poorly understood. In the present study, we control the fabrication of fluorescent mesoporous silica nanoparticles (MSNs) by varying the concentration of reaction reagents especially to design a series of shapes. Two different shaped fluorescent MSNs (aspect ratios, 1.5, 5) were specially designed, and the effects of particle shape on biodistribution, clearance and biocompatibility in vivo were investigated. Organ distributions show that intravenously administrated MSNs are mainly present in the liver, spleen and lung (>80%) and there is obvious particle shape effects on in vivo behaviors. Short-rod MSNs are easily trapped in the liver, while long-rod MSNs distribute in the spleen. MSNs with both aspect ratios have a higher content in the lung after PEG modification. We also found MSNs are mainly excreted by urine and feces, and the clearance rate of MSNs is primarily dependent on the particle shape, where short-rod MSNs have a more rapid clearance rate than long-rod MSNs in both excretion routes. Hematology, serum biochemistry, and histopathology results indicate that MSNs would not cause significant toxicity in vivo, but there is potential; Induction of binary excretion and glomerular filtration dysfunction. These findings may provide useful information for the design of nanoscale delivery systems and the environmental fate of nanoparticles.
引用
收藏
页码:5390 / 5399
页数:10
相关论文
共 50 条
  • [21] Tuning biodegradability and biocompatibility of mesoporous silica nanoparticles by doping strontium
    Guo, Xia
    Shi, Haishan
    Zhong, Weibing
    Xiao, Houhong
    Liu, Xu
    Yu, Tao
    Zhou, Changren
    CERAMICS INTERNATIONAL, 2020, 46 (08) : 11762 - 11769
  • [22] NEW INSIGHT IN POLYMERIC MICELLES AND MESOPOROUS SILICA NANOPARTICLES AND THEIR BIOCOMPATIBILITY
    Gorinova, C.
    Tzankov, B.
    Tzankova, V.
    Yoncheva, K.
    PHARMACIA, 2015, 62 (04) : 44 - 50
  • [23] Biocompatibility of Multi-Imaging Engineered Mesoporous Silica Nanoparticles: In Vitro and Adult and Fetal In Vivo Studies
    Sweeney, Sean
    Adamcakova-Dodd, Andrea
    Thorne, Peter S.
    Assouline, Jose G.
    JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2017, 13 (05) : 544 - 558
  • [24] Shape and Shear Stress Impact on the Toxicity of Mesoporous Silica Nanoparticles: In Vitro and In Vivo Evidence
    Cheng, Yaxin
    Tao, Jinsong
    Zhang, Yaqi
    Xi, Long
    Han, Run
    Xu, Meng
    Lee, Simon Ming-Yuen
    Ge, Wei
    Gan, Yong
    Zheng, Ying
    MOLECULAR PHARMACEUTICS, 2023, 20 (06) : 3187 - 3201
  • [25] In vivo characterization of the biodistribution for radiolabelled mesoporous nanoparticles for PET imaging
    Winter, G.
    Miller, L.
    Baur, B.
    Witulla, B.
    Solbach, C.
    Linden, M.
    Beer, A. J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S397 - S398
  • [26] Short-term biodistribution and clearance of intravenously administered silica nanoparticles
    Waegeneers, Nadia
    Brasseur, Anne
    Van Doren, Elke
    Van der Heyden, Sara
    Serreyn, Pieter-Jan
    Pussemier, Luc
    Mast, Jan
    Schneider, Yves-Jacques
    Ruttens, Ann
    Roels, Stefan
    TOXICOLOGY REPORTS, 2018, 5 : 632 - 638
  • [27] Mesoporous silica nanoparticles: Synthesis, pharmaceutical applications, biodistribution, and biosafety assessment
    Farjadian, Fatemeh
    Roointan, Amir
    Mohammadi-Samani, Soliman
    Hosseini, Majid
    CHEMICAL ENGINEERING JOURNAL, 2019, 359 : 684 - 705
  • [28] Mesoporous silica nanoparticles carrying multiple antibiotics provide enhanced synergistic effect and improved biocompatibility
    Gounani, Zahra
    Asadollahi, Mohammad A.
    Pedersen, Jannik. N.
    Lyngso, Jeppe
    Pedersen, Jan Skov
    Arpanaei, Ayyoob
    Meyer, Rikke L.
    COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 175 : 498 - 508
  • [29] Silica nanoparticles: Preparation, characterization and in vitro/in vivo biodistribution studies
    Tamba, B. I.
    Dondas, A.
    Leon, M.
    Neagu, A. N.
    Dodi, G.
    Stefanescu, C.
    Tijani, A.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2015, 71 : 46 - 55
  • [30] The Effect of Size and Shape of RNA Nanoparticles on Biodistribution
    Jasinski, Daniel L.
    Li, Hui
    Guo, Peixuan
    MOLECULAR THERAPY, 2018, 26 (03) : 784 - 792